Jim Simons Cumberland Pharmaceuticals Inc Call Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPIX
# of Institutions
33Shares Held
3.39MCall Options Held
24.7KPut Options Held
21.3K-
Israel Englander Millennium Management LLC | New York, Ny599KShares$1.26 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX556KShares$1.17 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA412KShares$868,8680.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX281KShares$592,6330.0% of portfolio
-
J. Goldman & CO LP New York, NY208KShares$439,1810.02% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $30.9M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...